Perinatal Streptococcal Disease
Mostrando 1-3 de 3 artigos, teses e dissertações.
-
1. PREVALÊNCIA E PERFIL DE SUSCEPTIBILIDADE A DROGAS DE STREPTOCOCUS AGALACTIAE EM PARTURIENTES DO SUS, ATENDIDAS EM UMA MATERNIDADE DE JUIZ DE FORA / PREVALÊNCIA E PERFIL DE SUSCEPTIBILIDADE A DROGAS DE STREPTOCOCUS AGALACTIAE EM PARTURIENTES DO SUS, ATENDIDAS EM UMA MATERNIDADE DE JUIZ DE FORA
Streptococcus agalactiae or Group B of Lancefield (GBS) can be part of the microbiota of the human beings, colonizing especially the gastrointestinal and the genitourinary tract. Its medical importance is associated to the transmission to neonates during the delivery, which can result in severe infection. The prevalence of the GBS among pregnant women ranges
Publicado em: 2008
-
2. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Since its emergence 25 years ago, group B streptococcus has become recognized as a cause of serious illness in newborns, pregnant women, and adults with chronic medical conditions. Heavy colonization of the genital tract with group B streptococcus also increases the risk that a woman will deliver a preterm low-birthweight infant. Early-onset infections (occu
American Society for Microbiology.
-
3. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Group B Streptococcus (GBS) is an important perinatal pathogen. Because transplacentally acquired maternal antibodies to the GBS capsular polysaccharides (CPS) confer protection, prevention of infant disease may be possible after immunization of women. Unfortunately, the purified CPS of GBS are only variably immunogenic in adults; therefore to enhance immuno